Home » Pharma Blog Watch
Pharma Blog Watch
OxyContin
Patent Settlement (Patent Baristas)
In his entry, blogger Stephen Albainy-Jenei
discusses Purdue's settlement with Endo in a suit over OxyContin patents, which
had been previously ruled to be unenforceable due to "misrepresentations
to the U.S. Patent and Trademark Office about the painkiller's effectiveness."
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct